4
Changes in Ownership
ArriVent BioPharma, Inc. Filed Acc 0001104659-26-076566
Options or other derivatives
- Director acquired 13,562 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Nolet Chris Director | 2026-06-18 | Grant or award · Non-Qualified Stock Option (right to buy) | +13,562 | 13,562 | D: show line 1 in the form |
Loading xslF345X06/tm2618519-1_4seq1.xml…